Armistice Capital’s Zura Bio ZURA Stock Holding History

Armistice Capital’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.97M	Sell	1,507,000 -53,000	-3%	-$320K	0.16%	97
2025 Q4	$8.17M	Hold	1,560,000	–	–	0.1%	110
2025 Q3	$6.75M	Buy	1,560,000 +24,000	+2%	+$43.2K	0.1%	98
2025 Q2	$1.61M	Hold	1,536,000	–	–	0.03%	140
2025 Q1	$1.98M	Buy	1,536,000 +36,000	+2%	+$56.8K	0.03%	149
2024 Q4	$3.75M	Hold	1,500,000	–	–	0.05%	128
2024 Q3	$6.09M	Sell	1,500,000 -1,024,000	-41%	-$3.83M	0.1%	112
2024 Q2	$8.83M	Buy	2,524,000 +876,000	+53%	+$3.57M	0.11%	97
2024 Q1	$4.24M	Sell	1,648,000 -176,000	-10%	-$624K	0.06%	129
2023 Q4	$8.52M	Buy	1,824,000 +244,000	+15%	+$1.22M	0.12%	99
2023 Q3	$10.4M	Buy	1,580,000 +630,000	+66%	+$4.21M	0.16%	85
2023 Q2	$7.79M	Buy	+950,000	New	+$7.63M	0.11%	103

Other funds holding ZURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Armistice Capital's ZURA Position: Q1 2026 in Review

Armistice Capital reduced its Zura Bio (ZURA) stake by 3.4% in Q1 2026, selling an estimated $320K and leaving 1,507,000 shares worth $8.97M. The position accounts for 0.16% of the portfolio, ranked #97.

Armistice Capital first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. The position peaked at $10.4M in Q3 2023. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

Armistice Capital held 1,507,000 shares of Zura Bio worth $8.97M as of Q1 2026.
Armistice Capital sold 53,000 Zura Bio shares in Q1 2026, an estimated $320K.
Zura Bio made up 0.16% of Armistice Capital's portfolio in Q1 2026, its #97 holding.
Armistice Capital first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
Armistice Capital's Zura Bio position peaked at $10.4M in Q3 2023.
94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.